Alyssa Kallman is currently the Director of Global Access Strategy and Pricing for Precision Medicines and Lung Cancer at Pfizer, a position held since 2025. Previously, they served as a Senior Manager in Strategic Analytics & Intelligence at Genentech and held various roles at Simon-Kucher & Partners, progressing from Consultant to Senior Consultant and Manager between 2022 and 2023. Alyssa started their career with internships at Invitrx Therapeutics and Zymo Research Corp in 2013 and 2014, respectively. Alyssa holds a Bachelor of Science in Microbiology, Immunology, and Molecular Genetics from the University of California, Los Angeles, and a PhD in Human Genetics from The Johns Hopkins University School of Medicine.
This person is not in any teams
This person is not in any offices